Furthermore, GLP-1RAs have shown enhanced efficacy in improving hepatic steatosis, reducing fibrosis, and modulating inflammation, suggesting promising therapeutic potential in metabolic dysfunction-associated steatohepatitis and cardiovascular comorbidities [11]
Therefore, it would be best to be wary of anyone who claims there is such a thing, or a product that claims to do so
The compound has been characterised across multiple research streams covering NNMT enzyme inhibition mechanism, adipocyte and obesity research, methyl-donor pool conservation, NAD+ pathway research, cancer-research framings (NNMT overexpression in tumours)
Consult a Heally licensed provider to determine which medication is right for you
The investigated GLP-1 receptor agonists included tirzepatide, efpeglenatide, liraglutide, albiglutide, dulaglutide, exenatide, semaglutide, and lixisenatide